Leissing TM., Hardy AP., Chan H., Wang Y., Tumber A., Chowdhury R., Feng T., Coleman ML., Cockman ME., Kramer HB., Berridge G., Fischer R., Kessler BM., Ratcliffe PJ., Lu X., Schofield CJ.

The aspariginyl hydroxylase human factor inhibiting hypoxia-inducible factor (FIH) is an important regulator of the transcriptional activity of hypoxia-inducible factor. FIH also catalyzes the hydroxylation of asparaginyl and other residues in ankyrin repeat domain-containing proteins, including apoptosis stimulating of p53 protein (ASPP) family members. ASPP2 is reported to undergo a single FIH-catalyzed hydroxylation at Asn-986. We report biochemical and crystallographic evidence showing that FIH catalyzes the unprecedented post-translational hydroxylation of both asparaginyl residues in "VNVN" and related motifs of ankyrin repeat domains in ASPPs (i.e., ASPP1, ASPP2, and iASPP) and the related ASB11 and p18-INK4C proteins. Our biochemical results extend the substrate scope of FIH catalysis and may have implications for its biological roles, including in the hypoxic response and ASPP family function.

Factor inhibiting HIF can catalyze two asparaginyl hydroxylations in VNVN motifs of ankyrin fold proteins.

Leissing TM., Hardy AP., Chan H., Wang Y., Tumber A., Chowdhury R., Feng T., Coleman ML., Cockman ME., Kramer HB., Berridge G., Fischer R., Kessler BM., Ratcliffe PJ., Lu X., Schofield CJ.

DOI

Type

Journal

Publication Date

Volume

Addresses

Keywords